DYNAMIC AI: Digital Innovation With Remote Management and Predictive Modelling to Integrate COPD Care With Artificial Intelligence-based Insights: An Acceptability, Feasibility and Safety Study
DYNAMIC AI
Digital Innovation With Remote Management and Predictive Modelling to Integrate COPD Care With Artificial Intelligence-based Insights: An Acceptability, Feasibility and Safety Study
1 other identifier
observational
500
1 country
1
Brief Summary
DYNAMIC AI is an MHRA-regulated medical device trial that will examine the feasibility of using AI predictive models within COPD multi-disciplinary team meetings, to allow clinicians to prioritise and optimise COPD management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 13, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedJune 22, 2023
June 1, 2023
1 year
June 13, 2023
June 13, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Acceptability to patients
Evaluation of acceptability to patients with COPD of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C : Evaluation will be based on proportion of patients invited who consent to participate in the DYNAMIC-AI study.
12 months
Technical feasibility
Technical Feasability of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C: Evaluation of feasibility will be proportion of participants with have adequate source data in LenusCOPD and who have 12-month mortality model-risk scores calculated and presented for MDT review in the AI-insights model app
12 months
Safety
Safety of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C Evaluation of safety will be based on occurrence of device-related adverse events and from the prospective evaluation of model risk scores - actions of clinicians based on model risk scores and calibration of predicted events : occurred events
12 months
Secondary Outcomes (4)
acceptability and technical feasibility experience
12 months
Expand dataset for training and validation
12 months
Evaluate technical feasibility and descriptive adoption experience
12 months
preliminary experience and utility dataset
12 months
Interventions
Predictive AI Model Risk score
Eligibility Criteria
People with COPD living within NHS Greater Glasgow and Clyde Health Board
You may qualify if:
- Current active user of NHS Scotland COPD digital service. Resident and under care of NHS GG\&C COPD multidisciplinary team. Consent, access to technology (smartphone, tablet, computer and daily internet access), ability to understand written English and confirmed diagnosis of COPD are requirements for use of the COPD digital service
You may not qualify if:
- Lack of provision of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- Lenus Healthcollaborator
- University of Glasgow Robertson Centre for Bio Statisticscollaborator
Study Sites (1)
Queen Elizabeth University Hospital
Glasgow, Scotland, G51 4TF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2023
First Posted
June 22, 2023
Study Start
April 1, 2023
Primary Completion
March 31, 2024
Study Completion
August 31, 2024
Last Updated
June 22, 2023
Record last verified: 2023-06